The Identification of Novel Therapeutic Biomarkers in Rheumatoid Arthritis: A Combined Bioinformatics and Integrated Multi-Omics Approach
Выявление новых терапевтических биомаркеров ревматоидного артрита: комбинированный биоинформатический и интегрированный мультиомный подход
2025-03-19
SCID: 54.1/eddrgukg
Discuss with AI
EpigenomicsIntegrated multi-omicsMulti-evidence genesRheumatoid arthritisTranscriptomics
Figures from the paper
Abstract (AI)
Rheumatoid arthritis (RA) is a multifaceted autoimmune disease that is marked by a complex molecular profile influenced by an array of factors, including genetic, epigenetic, and environmental elements. Despite significant advancements in research, the precise etiology of RA remains elusive, presenting challenges in developing innovative therapeutic markers. This study takes an integrated multi-omics approach to uncover novel therapeutic markers for RA. By analyzing both transcriptomics and epigenomics datasets, we identified common gene candidates that span these two omics levels in patients diagnosed with RA. Remarkably, we discovered eighteen multi-evidence genes (MEGs) that are prevalent across transcriptomics and epigenomics, twelve of which have not been previously linked directly to RA. The bioinformatics analyses of the twelve novel MEGs revealed they are part of tightly interconnected protein-protein interaction networks directly related to RA-associated KEGG pathways and gene ontology terms. Furthermore, these novel MEGs exhibited direct interactions with miRNAs linked to RA, underscoring their critical role in the disease's pathogenicity. Overall, this comprehensive bioinformatics approach opens avenues for identifying new candidate markers for RA, empowering researchers to validate these markers efficiently through experimental studies. By advancing our understanding of RA, we can pave the way for more effective therapies and improved patient outcomes.
Key Findings
1
An integrated transcriptomic and epigenomic analysis identified 18 multi-evidence genes consistently associated with rheumatoid arthritis.
2
The 12 novel genes form tightly interconnected protein–protein interaction networks enriched in rheumatoid arthritis-associated KEGG pathways and Gene Ontology terms.
3
The identified genes provide candidate therapeutic biomarkers for experimental validation and future rheumatoid arthritis treatment development.
4
The novel candidate genes directly interact with rheumatoid arthritis-related microRNAs, supporting potential roles in disease pathogenesis.
5
Twelve of the 18 multi-evidence genes represent novel candidate rheumatoid arthritis markers not previously directly linked to the disease.
Research Object
Rheumatoid arthritis and its transcriptomic and epigenomic molecular profiles
Research Subject
Identification and characterization of novel therapeutic multi-evidence gene biomarkers and their molecular interactions associated with rheumatoid arthritis
Publication Details
Publication Date
2025-03-19
Journal
Publisher
ISSN
Cited by
13
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest